DiscoverThe Elective Rotation: A Critical Care Hospital Pharmacy Podcast1074: Data supporting cefazolin in MSSA bacteremia was weak (until now)
1074: Data supporting cefazolin in MSSA bacteremia was weak (until now)

1074: Data supporting cefazolin in MSSA bacteremia was weak (until now)

Update: 2025-10-30
Share

Description

Show notes at pharmacyjoe.com/episode1074.


In this episode, I'll discuss the evidence supporting using cefazolin for MSSA bacteremia.


The post 1074: Data supporting cefazolin in MSSA bacteremia was weak (until now) appeared first on Pharmacy Joe.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

1074: Data supporting cefazolin in MSSA bacteremia was weak (until now)

1074: Data supporting cefazolin in MSSA bacteremia was weak (until now)

Pharmacy Joe